Diabetes Metab J.  2019 Dec;43(6):917-918. 10.4093/dmj.2019.0216.

Response: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)

Affiliations
  • 1Department of Ophthalmology, Ajou University School of Medicine, Suwon, Korea. kie114@ajou.ac.kr
  • 2Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea. djkim@ajou.ac.kr
  • 3Cardiovascular and Metabolic Disease Etiology Research Center, Ajou University School of Medicine, Suwon, Korea.

Abstract

No abstract available.


MeSH Terms

Cohort Studies*
Diabetic Retinopathy*
Hypoglycemic Agents*
Metformin*
Hypoglycemic Agents
Metformin
Full Text Links
  • DMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr